Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach

References

• Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis: an update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015 Jul;192(2):e3–19.
   PubMed Web of Science ®Google Scholar
• American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002 Jul;165(2):277–304.
   PubMedGoogle Scholar
• Flaherty KR, King TE, Raghu G, et al. Idiopathic Interstitial Pneumonia. Am J Respir Crit Care Med. 2004 Oct;170(8):904–910.
   PubMed Web of Science ®Google Scholar
• Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT Statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011 Mar;183(6):788–824.
   PubMed Web of Science ®Google Scholar
• Travis WD, Costabel U, Hansell DM, et al. An official American thoracic society/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013 Sep;188(6):733–748.
   PubMed Web of Science ®Google Scholar
• Lynch DA, Sverzellati N, Travis WD, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner society white paper. Lancet Respir Med. 2018 Feb;6(2):138–153.
   PubMed Web of Science ®Google Scholar
• Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018 Sep;198(5):e44–68.
   PubMed Web of Science ®Google Scholar
• Singh S, Collins BF, Sharma BB, et al. Interstitial Lung Disease in India. Results of a Prospective Registry. Am J Respir Crit Care Med. Mar 2017;195(6):801–813.
   PubMed Web of Science ®Google Scholar
• Chaudhuri N, Spencer L, Greaves M, et al. A Review of the Multidisciplinary Diagnosis of Interstitial Lung Diseases: a Retrospective Analysis in a Single UK Specialist Centre. J Clin Med. 2016 Jul;5(8):66.
   PubMed Web of Science ®Google Scholar
• Thomeer M, Demedts M, Behr J, et al. Multidisciplinary interob-server agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur Respir J. 2008 Mar;31(3):585–591.
   PubMed Web of Science ®Google Scholar
• Jo HE, Glaspole IN, Levin KC, et al. Clinical impact of the interstitial lung disease multidisciplinary service. Respirology. 2016 Nov;21(8):1438–1444.
   PubMed Web of Science ®Google Scholar
• Theegarten D, Müller HM, Bonella F, et al. Diagnostic approach to interstitial pneumonias in a single centre: report on 88 cases. Diagn Pathol. 2012 Dec;7(1). DOI:10.1186/1746-1596-7-160.
   PubMedGoogle Scholar
• Raghu G, Remy-Jardin M, Myers J, et al. The 2018 Diagnosis of Idiopathic Pulmonary Fibrosis Guidelines: surgical Lung Biopsy for Radiological Pattern of Probable Usual Interstitial Pneumonia is Not Mandatory. Am J Respir Crit Care Med. 2019 Nov;200(9):1089–1092.
   PubMed Web of Science ®Google Scholar
• Richeldi L, Wilson KC, Raghu G, Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies,” Eur Respir J, vol. 52, no. 3, Sep. 2018, doi:10.1183/13993003.01485-2018.
   Web of Science ®Google Scholar
• Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: an Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022 May;205(9):e18–47.
   PubMed Web of Science ®Google Scholar
• Pastre J, Khandhar S, Barnett S, et al. Surgical Lung Biopsy for Interstitial Lung Disease. Safety and Feasibility at a Tertiary Referral Center. Ann Am Thorac Soc. 2021 Mar;18(3):460–467.
   PubMed Web of Science ®Google Scholar
• Hutchinson JP, Fogarty AW, McKeever TM, et al. In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011. Am J Respir Crit Care Med. 2016 May;193(10):1161–1167.
   PubMed Web of Science ®Google Scholar
• Hutchinson JP, McKeever TM, Fogarty AW, et al. Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997–2008. Eur Respir J. 2016 Nov;48(5). DOI:10.1183/13993003.00378-2016
   Web of Science ®Google Scholar
• Ryerson CJ, Corte TJ, Lee JS, et al. A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective. Am J Respir Crit Care Med. 2017 Nov;196(10):1249–1254.
   PubMed Web of Science ®Google Scholar
• Prasad JD, Mahar A, Bleasel J, et al., The interstitial lung disease multidisciplinary meeting: a position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology. 2017 Oct;22(7):1459–1472. DOI:10.1111/resp.13163
   PubMed Web of Science ®Google Scholar
• Graney BA, He C, Marll M, et al., Essential Components of an Interstitial Lung Disease Clinic. Chest. 2021 Apr;159(4):1517–1530.
   PubMed Web of Science ®Google Scholar
• Grewal JS, Morisset J, Fisher JH, et al. Role of a Regional Multidisciplinary Conference in the Diagnosis of Interstitial Lung Disease. Ann Am Thorac Soc. 2019 Apr;16(4):455–462. doi: 10.1513/AnnalsATS.201811-794OC.
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Mori K, Mikamo M, et al. Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multi-disciplinary discussion. Eur Respir J. 2019 May;53(5):1802243.
   PubMed Web of Science ®Google Scholar
• Flaherty KR, Wells AU, Cottin V, et al. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. N Engl J Med. 2019 Oct;381(18):1718–1727.
   PubMed Web of Science ®Google Scholar
• de Lorenzis E, Bosello SL, Varone F, et al. Multidisciplinary Evaluation of Interstitial Lung Diseases: new Opportunities Linked to Rheumatologist Involvement. Diagnostics. 2020 Sep;10(9):664.
   Web of Science ®Google Scholar
  de Lorenzis E, Bosello SL, Varone F, et al. Multidisciplinary Evaluation of Interstitial Lung Diseases: new Opportunities Linked to Rheumatologist Involvement. Diagnostics. 2020 Sep;10(9):664.
   Web of Science ®Google Scholar
• Cottin V, Selman M, Inoue Y, et al. Syndrome of Combined Pulmonary Fibrosis and Emphysema: an Official ATS/ERS/JRS/ALAT Research Statement. Am J Respir Crit Care Med. 2022 Aug;206(4):e7–41.
   PubMed Web of Science ®Google Scholar
• Jeong SO, Uh S, Park S, et al. Effects of patient satisfaction and confidence on the success of treatment of combined rheumatic disease and interstitial lung disease in a multidisciplinary outpatient clinic. Int J Rheum Dis. 2018 Aug;21(8):1600–1608.
   PubMed Web of Science ®Google Scholar
• Cottin V, Tomassetti S, Valenzuela C, et al. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: an International Working Group Perspective. Am J Respir Crit Care Med. 2022 Aug;206(3):247–259.
   PubMed Web of Science ®Google Scholar
• Tominaga J, Sakai F, Johkoh T, et al. Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: the effect of the integrated clinico-radiological assessment. Eur J Radiol. 2015 Dec;84(12):2640–2645.
   Google Scholar
• de Sadeleer LJ, Meert C, Yserbyt J, et al. Diagnostic Ability of a Dynamic Multidisciplinary Discussion in Interstitial Lung Diseases. Chest. 2018 Jun;153(6):1416–1423.
   PubMed Web of Science ®Google Scholar
• Raghu G, Remy-Jardin M, Ryerson CJ, et al. Diagnosis of Hypersensitivity Pneumonitis in Adults: an Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 Aug;202(3):e36–69.
   PubMed Web of Science ®Google Scholar
• Fernández Pérez ER, Swigris JJ, Forssén AV, et al. Identifying an Inciting Antigen is Associated with Improved Survival in Patients with Chronic Hypersensitivity Pneumonitis. Chest. 2013 Nov;144(5):1644–1651.
   PubMed Web of Science ®Google Scholar
• Polke M, Kirsten D, Teucher B, et al. A Comparison of Existing Questionnaires for Identifying the Causes of Interstitial and Rare Lung Diseases. Respiration. 2020;99(2):119–124.
   PubMed Web of Science ®Google Scholar
• Fernández Pérez ER, Travis WD, Lynch DA, et al. Diagnosis and Evaluation of Hypersensitivity Pneumonitis. Chest. 2021 Aug;160(2):e97–156.
   PubMed Web of Science ®Google Scholar
• Perluk TM, Friedman Regev I, Freund O, et al. Importance of physician history taking in complementing patient-reported interstitial lung disease questionnaire. BMC Pulm Med. 2022 Dec;22(1). DOI:10.1186/s12890-022-02294-3
   PubMed Web of Science ®Google Scholar
• CHEST Interstitial and Difuse Lung Disease Patient Questionnaire. 2022 Feb.
   Google Scholar
• Walsh SLF, Calandriello L, Sverzellati N, et al. Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT. Thorax. 2016 Jan;71(1):45–51.
   PubMed Web of Science ®Google Scholar
• Teoh AKY, Holland AE, Morisset J, et al. Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: an International Delphi Survey. Ann Am Thorac Soc. 2022 Jan;19(1):66–73.
   PubMed Web of Science ®Google Scholar
• Tomassetti S, Wells AU, Costabel U, et al. Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016 Apr;193(7):745–752.
   Google Scholar
• Troy LK, Grainge C, Corte TJ, et al. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. Lancet Respir Med. 2020 Feb;8(2):171–181.
   PubMed Web of Science ®Google Scholar
• Nicholson AG. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax. 2004 Jun;59(6). DOI:10.1136/thx.2003.011734
   Web of Science ®Google Scholar
• Flaherty KR, Travis W, Colby T, et al. Histopathologic Variability in Usual and Nonspecific Interstitial Pneumonias. Am J Respir Crit Care Med. 2001 Nov;164(9):1722–1727.
   PubMed Web of Science ®Google Scholar
• Fernandes L, Nasser M, Ahmad K, et al. Interstitial Pneumonia with Autoimmune Features (IPAF). Front Med. 2019 Sep; 6. DOI:10.3389/fmed.2019.00209
   Web of Science ®Google Scholar
• Fischer A, Antoniou KM, Brown KK, et al. ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015 Oct;46(4):976–87. doi: 10.1183/13993003.00150-2015.
   PubMed Web of Science ®Google Scholar
• Kalluri M, Claveria F, Ainsley E, et al. Beyond Idiopathic Pulmonary Fibrosis Diagnosis: multidisciplinary Care with an Early Integrated Palliative Approach is Associated with a Decrease in Acute Care Utilization and Hospital Deaths. J Pain Symptom Manage. 2018 Feb;55(2):420–426.
   PubMed Web of Science ®Google Scholar
• Jo HE, Troy LK, Keir G, et al. Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology. 2017 Oct;22(7):1436–1458.
   PubMed Web of Science ®Google Scholar
• Mackintosh JA, Glenn L, Barnes H, et al. Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19. Respirology. 2021 Jun;26(6):612–615.
   PubMed Web of Science ®Google Scholar
• Johannson KA, Lethebe BC, Assayag D, et al. Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung Disease. Ann Am Thorac Soc. 2022 Jan;19(1):20–27.
   PubMed Web of Science ®Google Scholar
• Althobiani M, Alqahtani JS, Hurst JR, et al. Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians. BMJ Open Respir Res. 2021 Dec;8(1):e001088.
   PubMed Web of Science ®Google Scholar
• Hambly N, Farooqi MM, Dvorkin-Gheva A, et al. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry. Eur Respir J. 2022 Oct;60(4):2102571.
   PubMed Web of Science ®Google Scholar
• Hamblin M, Prosch H, Vašáková M. Diagnosis, course and management of hypersensitivity pneumonitis. Eur Respir Rev. 2022 Mar;31(163). DOI:10.1183/16000617.0169-2021
   PubMed Web of Science ®Google Scholar
• Flaherty KR, Andrei A-C, King TE, et al. Idiopathic Interstitial Pneumonia. Am J Respir Crit Care Med. 2007 May;175(10):1054–1060.
   PubMed Web of Science ®Google Scholar
• Biglia C, et al. Multidisciplinary management of interstitial lung diseases: a real-life study. Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(2). DOI:10.36141/svdld.v36i2.8107
   PubMed Web of Science ®Google Scholar
• Walsh SLF, Wells AU, Desai SR, et al. Multicentre evaluation of multi-disciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med. 2016 Jul;4(7):557–565.
   PubMed Web of Science ®Google Scholar
• Walsh SLF, Maher TM, Kolb M, et al. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study. Eur Respir J. 2017 Aug;50(2):1700936.
   PubMed Web of Science ®Google Scholar
• Richeldi L, Launders N, Martinez F, et al. The characterisation of interstitial lung disease multidisciplinary team meetings: a global study. ERJ Open Res. 2019 Apr;5(2). DOI:10.1183/23120541.00209-2018
   Google Scholar
• Greene KE, King TE, Kuroki Y, et al. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J. 2002 Mar;19(3):439–446.
   PubMed Web of Science ®Google Scholar
• Ohnishi H, Yokoyama A, Kondo K, et al. Comparative Study of KL-6, Surfactant Protein-A, Surfactant Protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung Diseases. Am J Respir Crit Care Med. 2002 Feb;165(3):378–381.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Otsuka M, Chiba H, et al. Surfactant protein a as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis. BMC Pulm Med. 2020 Dec;20(1). DOI:10.1186/s12890-020-1060-y
   Web of Science ®Google Scholar
• Ikeda K, Chiba H, Nishikiori H, et al. Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in Japan. Respir Res. 2020 Dec;21(1). DOI:10.1186/s12931-020-01582-y
   Web of Science ®Google Scholar
• Collard HR, Calfee CS, Wolters PJ, et al. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L3–7.
   PubMed Web of Science ®Google Scholar
• Serum Kl-6 Levels Correlate with Response to Pirfenidone in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2015.
   Google Scholar
• Zhang D, Newton CA. Familial Pulmonary Fibrosis. Chest. 2021 Nov;160(5). DOI:10.1016/j.chest.2021.06.037
   Web of Science ®Google Scholar
• García-Sancho C, Buendía-Roldán I, Fernández-Plata MR, et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir med. 2011 Dec;105(12):1902–1907.
   PubMed Web of Science ®Google Scholar
• Ryerson CJ, Corte TJ, Myers JL, et al. A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease. Eur Respir J. 2021 Dec;58(6):2100276.
   PubMed Web of Science ®Google Scholar
• Hatabu H, Hunninghake GM, Richeldi L, et al. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society. Lancet Respir Med. 2020 Jul;8(7):726–737.
   PubMed Web of Science ®Google Scholar